STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2774 by analyst upside · 2026-08-13
IQV
IQVIA Holdings Inc.
Healthcare · Market Cap $40B · P/E 30.3x
ANALYST PRICE TARGET
+13.8%
implied upside to consensus target
Current Price $241.71
Consensus Target $275.17
Bull Target $300.0
Bear Target $240.0
Analysts Covering 18
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
13
Hold
2
Sell
0
52-Week Low $154.5
52-Week High $251.36
YTD Return +7.3%
FUNDAMENTALS
Market Cap $40B
P/E Ratio (TTM) 30.3x
Forward P/E 16.7x
EPS (TTM) $7.98
PEG Ratio 0.99
Dividend Yield N/A
Revenue (TTM) $17.0B
Profit Margin 8.1%
52-WEEK RANGE
52-Week Low $154.5
52-Week High $251.36
Current Price $241.71
Bear Target $240.0
Bull Target $300.0
● Now $241.71 ● Target $275.17
TRADING DATA
Avg Volume 1.6M
YTD Return +7.3%
Analyst Count 18
Consensus Buy
Upside to Target +13.8%
Last Updated 2026-08-13

ANALYST SUMMARY

IQVIA Holdings Inc. (IQV) is currently trading at $241.71 with a Wall Street consensus price target of $275.17, implying potential upside of 13.8% over the next 12 months. 18 analysts currently cover IQV, with a consensus rating of Buy - 89% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $300.0, while the most cautious has a target of $240.0.

IQV operates in the Healthcare sector with a market capitalisation of $40B. The stock is up 7.3% year-to-date and is currently trading near the upper end of its 52-week range of $154.5 – $251.36.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for IQV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley ↓ Downgrade
Overweight → Equal-Weight 2026-06-17 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-08 Building track record
TD Cowen ↑ Upgrade
Hold → Buy 2026-03-09 Building track record
Barclays ↑ Upgrade
Equal-Weight → Overweight 2026-03-06 Building track record
RBC Capital ● Initiated
Outperform 2026-03-03 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-02-19 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-02-06 43% win rate (7 calls)
Citigroup - Reiterated
Neutral → Neutral 2026-02-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
69
out of 100
Coverage depth
22/30
Consensus clarity
25/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →